- Home
- AGL vs BHC Comparison
AGL vs BHC Comparison
Compare AGL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGL | BHC |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AGL | BHC |
|---|---|---|
| Price | $99.27 | $4.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 3 |
| Target Price | ★ $55.68 | $8.00 |
| AVG Volume (30 Days) | 321.3K | ★ 2.7M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 2.94 | N/A |
| Revenue | $5,932,576,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | $4.23 | N/A |
| P/E Ratio | $34.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.30 | $4.33 |
| 52 Week High | $133.04 | $8.69 |
Technical Indicators
Market Signals| Indicator | AGL | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 35.75 |
| Support Level | $98.45 | N/A |
| Resistance Level | $129.38 | $6.31 |
| Average True Range (ATR) | 10.43 | 0.15 |
| MACD | -3.07 | -0.03 |
| Stochastic Oscillator | 6.19 | 16.30 |
Price Performance
Historical ComparisonAbout AGL agilon health inc.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.